Evidence map›Paper›PMID 35372676›Full record

ArticleTransplantation direct2022

The Utility of Noninvasive PET/CT Myocardial Perfusion Imaging in Adult Liver Transplant Candidates.

Monica A Tincopa, Richard L Weinberg, Shreya Sengupta, Jeremy Slivnick, James Corbett, Christopher J Sonnenday, Robert J Fontana, Pratima Sharma

Open access · goldAbstract read
In one paragraph

Article in Transplantation direct, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Cardiology Assessment of Patients Undergoing Evaluation for Orthotopic Liver Transplantation.Journal of the Society for Cardiovascular Angiography & Interventions
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Monica A TincopaDepartment of Internal Medicine, Division of Digestive Diseases, UCLA Health, Los Angeles, CA.
Richard L WeinbergDivision of Cardiovascular Medicine, Department of Surgery, University of Michigan Health System, Ann Arbor, MI.
Shreya SenguptaDivision of Gastroenterology and Hepatology, Department of Surgery, University of Michigan Health System, Ann Arbor, MI.
Jeremy SlivnickDivision of Cardiovascular Medicine, Ohio State University Wexner Medical Center, Columbus, OH.
James CorbettDivision of Cardiovascular Medicine, Department of Surgery, University of Michigan Health System, Ann Arbor, MI.
Christopher J SonnendayDivision of Gastroenterology and Hepatology, Department of Surgery, University of Michigan Health System, Ann Arbor, MI.
Robert J FontanaDivision of Gastroenterology and Hepatology, Department of Surgery, University of Michigan Health System, Ann Arbor, MI.
Pratima SharmaDivision of Gastroenterology and Hepatology, Department of Surgery, University of Michigan Health System, Ann Arbor, MI.
The Ohio State University Wexner Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The optimal cardiovascular (CV) risk stratification in liver transplant (LT) candidates remains unclear. The aim of this study was to evaluate concordance of findings between dobutamine stress echocardiography (DSE), positron emission tomography/computed tomography myocardial perfusion imaging (PET/CT MPI), and left heart catheterization in adult LT candidates. Methods: Data on 234 consecutive adult LT candidates from February 2015 to June 2018 with PET/CT MPI were reviewed. Adverse CV outcomes were adjudicated via chart review by a board-certified cardiologist. Results: Median age was 60.8, body mass index 30.2 kg/m Conclusions: Results of different cardiac risk-stratification modalities were concordant across modalities the majority of the time in LT candidates, although these findings were not independently correlated with risk of post-LT CV outcomes. Given the high rates of nondiagnostic DSEs in this population, PET/CT MPI may be the preferred CV risk-stratification modality in older patients and those with known CV disease.

Identifiers

PMID35372676
PMCPMC8963847
OpenAlexW4220767367

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.